ORTHOBIOLOGICS MARKET ANALYSIS

Orthobiologics Market, By Product Type (Bone Allograft, Machined Bones, Demineralized Bone Matrix, Synthetic Bone Substitutes, Bone Morphogenetic Protein (BMP), and Others), By Application (Spinal Fusion, Trauma Fixation, Reconstructive Joint Surgery, and Others), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Apr 2024
Code : CMI1306
Pages :145
Formats :
Excel and PDF
Industry : Medical Devices

Market Concentration and Competitive Landscape

Orthobiologics Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Product Launches by Key Market Players

The adoption of inorganic growth strategies such as product launches by key market players is expected to drive the global orthobiologics market growth over the forecast period. For instance, in July 2022, Ossifix Orthopedics, a subsidiary of Umbra Applied Technologies Group, Inc., a medical technology company, announced that it had launched crunch, a demineralized bone matrix that contains cancellous bone fragments to provide the osteoconductive scaffolding to promote new bone growth. This product launch will expand its suite of orthopedic products.

Key Players Insights